Breaking News Instant updates and real-time market news.

MYOV

Myovant Sciences

$22.42

-0.13 (-0.58%)

16:39
08/07/18
08/07
16:39
08/07/18
16:39

Myovant Sciences reports Q1 EPS (98c), consensus (85c)

MYOV Myovant Sciences
$22.42

-0.13 (-0.58%)

04/05/18
LEHM
04/05/18
NO CHANGE
LEHM
Barclays upgrades Merck, downgrades Biogen and Pfizer in sector reassessment
Barclays analyst Geoff Meacham made some rating changes while reassessing the Biopharmaceutical sector. Biopharma sentiment has been negative since the start of 2018, despite a modest pick-up in deals and diminished rhetoric on drug pricing, Meacham tells investors in a research note titled "U.S. Biopharmaceuticals: Where to from here?" The analyst believes "more transformative" acquisitions, "clean" Phase 3 wins, and even a relatively strong Q1 earnings season could help "re-rate the sector" and get investors more engaged in the group. Ahead of the Q1 earnings season, Meacham upgraded Merck (MRK) to Overweight from Equal Weight and downgraded to Equal Weight from Overweight shares of Biogen (BIIB), Pfizer (PFE), Biohaven Pharmaceutical (BHVN) and Myovant Sciences (MYOV). The analyst also lowered his price target for Equal Weight-rated AbbVie (ABBV) to $102 from $120, for Equal Weight-rated Amgen (AMGN) to $180 from $180, for Overweight-rated Prothena (PRTA) to $50 from $70 and for Overweight-rated Incyte (INCY) to $135 from $165.
04/05/18
04/05/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Hold from Buy at Stifel with analyst Kevin Cassidy citing the peaking server central processing unit cycle and valuation for the downgrade. 2. Johnson Controls (JCI) downgraded to Underperform from Sector Perform at RBC Capital with analyst Deane Dray citing the company's exposure to additional cash flow pressures in fiscal 2018, reduction in fiscal 2020 targets, and a market rotation toward "more defensive names." 3. Ryder (R) downgraded to Underweight from Neutral at JPMorgan with analyst Brian Ossenbeck saying he is making a "longer term call on 2019 expectations," which he believes are too high and embed "significant gains on residual values and used truck sales." 4. Ollie's Bargain Outlet (OLLI) downgraded to Neutral from Buy at BofA/Merrill with analyst Elizabeth Suzuki saying valuation is getting "richer," quarterly comps have been decelerating since 2015, and are now expected to be 1%-2% in 2018. 5. Biogen (BIIB), Pfizer (PFE), Biohaven (BHVN), and Myovant Sciences (MYOV) were downgraded to Equal Weight from Overweight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/25/18
SBSH
04/25/18
NO CHANGE
Target $44
SBSH
Buy
Myovant Sciences price target raised to $44 from $17 at Citi
Citi analyst Robyn Karnauskas raised her price target for Myovant Sciences to $44 from $17 saying now is the time to own the shares. The analyst expects the initial Phase 3 endometriosis/uterine fibroids data expected in 12-18 months to be positive. She believes it is time to assign full credit to Relugolix in the U.S. for endometriosis/uterine fibroids. The analyst thinks the trials will be successful and is giving 100% probability in endometriosis and uterine fibroids in the U.S. and 50% in Europe as well as 50% credit in prostate cancer worldwide. Karnauskas keeps a Buy rating on Myovant.
07/24/18
SBSH
07/24/18
NO CHANGE
SBSH
Buy
Citi says Myovant may have $102 upside if relugolix priced at parity to elagolix
After AbbVie (ABBV) and Neurocrine Biosciences (NBIX) announced that the FDA approved elagolix and Neurocrine said the list price has been set at $28 per day, Citi analyst Robyn Karnauskas noted that she currently models Myovant Sciences' (MYOV) relugolix priced at $10 per day. Modeling relugolix pricing at parity to elagolix and assuming a gross-to-net of 100% would lead to a fair value estimate for Myovant of $146, or the equivalent of $102 of upside from her current price target of $44, Karnauskas stated. The analyst, who models a split market between relugolix and elagolix in endometriosis, keeps a Buy rating on Myovant shares.

TODAY'S FREE FLY STORIES

SIG

Signet Jewelers

$17.49

-0.13 (-0.74%)

11:25
06/24/19
06/24
11:25
06/24/19
11:25
Options
Signet Jewelers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVTY

Tivity Health

$17.18

-0.23 (-1.32%)

11:24
06/24/19
06/24
11:24
06/24/19
11:24
Conference/Events
Tivity Health management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 14

    Aug

  • 15

    Aug

11:20
06/24/19
06/24
11:20
06/24/19
11:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
06/24/19
06/24
11:17
06/24/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
06/24/19
06/24
11:16
06/24/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$100.87

-1.29 (-1.26%)

11:15
06/24/19
06/24
11:15
06/24/19
11:15
Options
UPS put volume heavy and directionally bearish »

Bearish flow noted in UPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 24

    Jul

11:15
06/24/19
06/24
11:15
06/24/19
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
06/24/19
06/24
11:15
06/24/19
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

SRPT

Sarepta

$127.90

-2.01 (-1.55%)

, PFE

Pfizer

$43.59

-0.09 (-0.21%)

11:11
06/24/19
06/24
11:11
06/24/19
11:11
On The Fly
Before the Move: Watch Sarepta ahead of Pfizer's DMD gene therapy data »

Ahead of the Parent…

SRPT

Sarepta

$127.90

-2.01 (-1.55%)

PFE

Pfizer

$43.59

-0.09 (-0.21%)

SLDB

Solid Biosciences

$4.91

-0.07 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 19

    Aug

  • 28

    Aug

  • 16

    Sep

GLW

Corning

$33.15

-0.1 (-0.30%)

11:08
06/24/19
06/24
11:08
06/24/19
11:08
Recommendations
Corning analyst commentary at JPMorgan »

Drop in LCD TV panel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSN

Tyson Foods

$81.18

1.87 (2.36%)

11:05
06/24/19
06/24
11:05
06/24/19
11:05
Options
Tyson Foods call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$45.86

-3.5 (-7.09%)

, CELG

Celgene

$94.16

-4.76 (-4.81%)

10:59
06/24/19
06/24
10:59
06/24/19
10:59
Periodicals
Bristol-Myers' merger headaches could be 'contagious,' STAT News says »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$45.86

-3.5 (-7.09%)

CELG

Celgene

$94.16

-4.76 (-4.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 25

    Jul

  • 03

    Sep

  • 16

    Sep

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

LN

Line Corp.

$28.08

-0.17 (-0.60%)

10:54
06/24/19
06/24
10:54
06/24/19
10:54
Upgrade
Line Corp. rating change  »

Line Corp. now fairly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FXI

iShares China Large-Cap ETF

$42.65

0.15 (0.35%)

10:50
06/24/19
06/24
10:50
06/24/19
10:50
Options
Heavy call volume in China Largecap ETF adjusts existing position »

Heavy call volume in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAVM

PAVmed

$1.24

0.015 (1.22%)

10:49
06/24/19
06/24
10:49
06/24/19
10:49
Hot Stocks
PAVmed announces FDA 510(k) clearance for EsoCheck »

PAVmed announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

LN

Line Corp.

$28.08

-0.17 (-0.60%)

10:46
06/24/19
06/24
10:46
06/24/19
10:46
Upgrade
Line Corp. rating change at Goldman Sachs »

Line Corp. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBX

Dropbox

$25.29

0.3 (1.20%)

10:45
06/24/19
06/24
10:45
06/24/19
10:45
Options
Dropbox call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
06/24/19
06/24
10:45
06/24/19
10:45
General news
U.S. Dallas Fed manufacturing index dropped another 6.8 points to -12.1 in June »

U.S. Dallas Fed…

AMZN

Amazon.com

$1,906.00

-4.42 (-0.23%)

, ULTA

Ulta Beauty

$354.70

-1.07 (-0.30%)

10:41
06/24/19
06/24
10:41
06/24/19
10:41
Hot Stocks
Amazon Business launches Amazon Professional Beauty Store »

Amazon (AMZN) has…

AMZN

Amazon.com

$1,906.00

-4.42 (-0.23%)

ULTA

Ulta Beauty

$354.70

-1.07 (-0.30%)

SBH

Sally Beauty

$14.65

-0.14 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 10

    Jul

  • 29

    Aug

AEGN

Aegion

$16.86

0.17 (1.02%)

10:38
06/24/19
06/24
10:38
06/24/19
10:38
Hot Stocks
Aegion appoints John Heggemann Chief Accounting Officer »

Aegion Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:37
06/24/19
06/24
10:37
06/24/19
10:37
General news
Dallas Fed Mfg Survey General Activity Index data reported »

June Dallas Fed Mfg…

NOW

ServiceNow

$282.05

-3.7 (-1.29%)

10:35
06/24/19
06/24
10:35
06/24/19
10:35
Options
ServiceNow put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$40.80

-0.26 (-0.63%)

10:33
06/24/19
06/24
10:33
06/24/19
10:33
Conference/Events
Biohaven Pharmaceutical management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

LVS

Las Vegas Sands

$59.26

0.08 (0.14%)

10:25
06/24/19
06/24
10:25
06/24/19
10:25
Options
Las Vegas Sands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPLK

Splunk

$123.84

-0.41 (-0.33%)

, HMSY

HMS Holdings

$31.56

-0.3 (-0.94%)

10:24
06/24/19
06/24
10:24
06/24/19
10:24
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

SPLK

Splunk

$123.84

-0.41 (-0.33%)

HMSY

HMS Holdings

$31.56

-0.3 (-0.94%)

CNCE

Concert Pharmaceuticals

$11.60

0.7 (6.42%)

AWI

Armstrong World

$97.57

-0.25 (-0.26%)

RMTI

Rockwell Medical

$3.03

0.04 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 09

    Jul

  • 11

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.